Hyderabad : A senior official from India’s department of pharmaceuticals Thursday visited US Pharmacopeia’s (USP) facility here.
Sudhansh Pant, joint secretary in the department, went around the facility and met scientists.
“The purpose of this visit was to better understand the efforts USP is making in India to create standards for medicines, ensure full safety and quality of medicines and bring to India international standards in drug manufacture,” said a statement by the organisation.
The official’s discussion with USP India touched upon various aspects of ensuring the quality of medicines in India and how USP standards could help Indian manufacturers to export their products both to the US and to other countries.
Impressed by the facility, Pant noted the commendable work is being done in the field of standards, testing and research and the various collaborations in the interest of the Indian pharmaceutical industry. He hoped that other governments and private institutions will benefit from the presence of USP’s world class facility in Hyderabad.
“We see ourselves as partners in India’s efforts to produce safe and high quality medicines that meet all global standards. We hope to continue with future engagements with the DoP on various aspects related to quality of medicines and to address issues of critical importance to patient safety,” said K.V. Surendranath, senior vice president- International Sites Operations, USP-India.
Set up in 2005, it is the first collaborative testing laboratory facility and office of USP outside the US.
Staffed by more than 100 professionals from India, it supports USP’s global efforts to set standards for the identity, strength, quality, and purity of drugs, food ingredients, and dietary supplements.